Andrew Cittadine

Company: Monopar Therapeutics

Job title: COO

Seminars:

Pharmacokinetics, Dosimetry, & Imaging: Radiopharmaceuticals Show the Whole Picture 1:33 pm

Traditional drug development has well established assays, tools and technologies for preclinical research, but specialized tools in evolving world of radiopharmaceuticals offer powerful advantages. Delve into this workshop to explore: Preclinical Imaging for PK Evaluation: Discover how tools like PET and SPECT are utilized in preclinical models to quickly visualize and quantify radiopharmaceutical biodistribution, uptake,…Read more

day: Pre-Conference Workshop Day

uPAR: A Promising Novel Radiopharmaceutical Target for Solid Tumors 9:30 am

Revealing why uPAR is a promising radiopharma target and what characteristics make it particularly appealing Sharing the strategy that went into creating Monopar’s targeting agent against uPAR Optimizing biodistribution preclinically and how that translatedRead more

day: Conference Day One